目的 分析不同年龄段儿童Delta变异株感染所致新型冠状病毒感染患儿的临床特征，为儿童新型冠状病毒感染的临床诊疗提供参考。 方法 将2021年11月17日—12月17日河南省定点救治医院收治的Delta变异株感染所致的新型冠状病毒感染患儿45例分为3组（<6岁组16例，6~13岁组16例，>13岁组13例），比较3组患儿的临床特征及实验室检查结果。 结果 各年龄组均以轻型病例为主，均以咳嗽、咳痰为主要临床表现，发热仅在6~13岁组中出现。<6岁组血清天冬氨酸氨基转移酶、乳酸脱氢酶、肌酸激酶同工酶水平高于其他两组（P<0.05）。6~13岁组血肌酐水平升高患儿比例最高，达50%。仅>13岁组中4例患儿出现血清C反应蛋白增高。在3个年龄组中，6~13岁组外周血CD3+CD4+ 淋巴细胞、CD3+CD8+ 淋巴细胞及自然杀伤细胞计数均最低。>13岁组入院时SARS-CoV-2 IgG阳性率高于其他两组（P<0.05）。3组患儿胸部CT影像学表现差异无统计学意义（P>0.05）。 结论 不同年龄段患儿Delta变异株感染所致的新型冠状病毒感染的临床特征可能存在差异：<6岁患儿可能更易出现心肌损害；6~13岁患儿除出现咳嗽、咳痰等临床症状外，还可出现发热，且可能更易发生肾功能及免疫功能损害。
Abstract
Objective To study the clinical features of children with coronavirus disease 2019 (COVID-19) caused by Delta variant infection in different ages groups. Methods A total of 45 children with COVID-19 caused by Delta variant infection who were hospitalized in the designated hospital in Henan Province, China, from November 17 to December 17, 2021, were included. They were divided into three groups: <6 years group (n=16), 6-13 years group (n=16), and >13 years group (n=13). The three groups were compared in clinical features and laboratory examination data. Results COVID-19 in all age groups was mainly mild. Main manifestations included cough and expectoration in the three groups, and fever was only observed in the 6-13 years group. The <6 years group had significantly higher serum levels of aspartate aminotransferase, lactate dehydrogenase, and creatine kinase isoenzymes than the other two groups (P<0.05). The 6-13 years group had the highest proportion of children with elevated serum creatinine levels (50%). Among the three groups, only 4 children in the >13 years group had an increase in serum C-reactive protein levels. The 6-13 years group had the lowest counts of CD3+CD4+ lymphocytes, CD3+CD8+ lymphocytes, and natural killer cells in the peripheral blood among the three groups. The >13 years group had a significantly higher positive rate of SARS-CoV-2 IgG on admission than the other two groups (P<0.05). There was no significant difference in the imaging findings on chest CT among the three groups (P>0.05). Conclusions The clinical features of COVID-19 caused by Delta variant infection in children of different age groups may be different: children aged <6 years tend to develop myocardial injury, and those aged 6-13 years have fever except cough and expectoration and tend to develop renal and immune dysfunction.
关键词
新型冠状病毒感染 /
Delta变异株 /
临床特征 /
儿童
Key words
Coronavirus disease 2019 /
Delta variant /
Clinical feature /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 姜心怡, 周文浩. 新型冠状病毒肺炎对儿童神经系统的影响[J]. 中国当代儿科杂志, 2021, 23(5): 530-535. PMID: 34020746. PMCID: PMC8140346. DOI: 10.7499/j.issn.1008-8830.2012115.
2 吴俣, 刘民. 不同新型冠状病毒变异株感染的COVID-19潜伏期研究[J]. 中国全科医学, 2022, 25(11): 1309-1313. DOI: 10.12114/j.issn.1007-9572.2022.0078.
3 Chen S, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513. PMID: 32007143. PMCID: PMC7135076. DOI: 10.1016/S0140-6736(20)30211-7.
4 Farinholt T, Doddapaneni H, Qin X, et al. Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections[J]. BMC Med, 2021, 19(1): 255. PMID: 34593004. PMCID: PMC8483940. DOI: 10.1186/s12916-021-02103-4.
5 盛俊峰, 邵兰, 王于林. 11例Delta变异株新型冠状病毒肺炎儿童病例的临床特征分析[J]. 中国当代儿科杂志, 2021, 23(12): 1267-1270. PMID: 34911611. PMCID: PMC8690709. DOI: 10.7499/j.issn.1008-8830.2110043.
6 Albitar O, Ballouze R, Ooi JP, et al. Risk factors for mortality among COVID-19 patients[J]. Diabetes Res Clin Pract, 2020, 166: 108293. PMID: 32623035. PMCID: PMC7332436. DOI: 10.1016/j.diabres.2020.108293.
7 蒋荣猛, 谢正德, 姜毅, 等. 儿童新型冠状病毒感染诊断、治疗和预防专家共识(第三版)[J]. 中华实用儿科临床杂志, 2021, 36(10): 721-732. DOI: 10.3760/cma.j.cn101070-20210226-00235.
8 中华人民共和国国家卫生健康委员会. 儿童血细胞分析参考区间: WS/T 779-2021[S]. 北京: 中国标准出版社, 2021.
9 中华人民共和国国家卫生健康委员会. 儿童临床常用生化检验项目参考区间: WS/T 780-2021[S]. 北京: 中国标准出版社, 2021.
10 杨艳娟, 魏晓娴, 郑冉, 等. 云南省瑞丽市新型冠状病毒感染/肺炎成人和儿童本土病例的流行病学及临床特征[J]. 中国循证儿科杂志, 2021, 16(5): 338-343. DOI: 10.3969/j.issn.1673-5501.2021.05.003.
11 蔡妙甜, 李侗曾, 张龙玉, 等. 93例成人新型冠状病毒肺炎患者临床特征及预后危险因素的回顾性分析[J]. 中国全科医学, 2021, 24(2): 196-204. DOI: 10.12114/j.issn.1007-9572.2021.00.056.
12 Babapoor-Farrokhran S, Gill D, Walker J, et al. Myocardial injury and COVID-19: possible mechanisms[J]. Life Sci, 2020, 253: 117723. PMID: 32360126. PMCID: PMC7194533. DOI: 10.1016/j.lfs.2020.117723.
13 易兰芬, 邱梅, 文红霞. 新型冠状病毒感染儿童心肌损伤的研究[J]. 临床儿科杂志, 2020, 38(12): 905-907. DOI: 10.3969/j.issn.1000-3606.2020.12.006.
14 罗飞, 李树仁, 郝潇, 等. 新型冠状病毒肺炎相关心肌炎发病机制的研究进展[J]. 中国全科医学, 2021, 24(20): 2589-2593. DOI: 10.12114/j.issn.1007-9572.2021.00.524.
15 唐子健, 李树仁, 许文华, 等. 从2019-nCoV和SARS-CoV的侵袭靶点血管紧张素转化酶2寻找新型冠状病毒肺炎的救治策略[J]. 中国全科医学, 2020, 23(9): 1071-1077. DOI: 10.12114/j.issn.1007-9572.2020.00.251.
16 Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection[J]. Nat Commun, 2021, 12(1): 2506. PMID: 33947851. PMCID: PMC8096808. DOI: 10.1038/s41467-021-22781-1.
17 高梦圆, 赵泳冰, 刘玺, 等. 新冠肺炎患者肝肾功能损害的临床特征及其与重症及死亡的相关性分析[J]. 第三军医大学学报, 2021, 43(20): 2241-2249. DOI: 10.16016/j.1000-5404.202105042.
18 王继婷, 李俊, 田塬, 等. 新型冠状病毒肺炎病情严重程度与预后指标相关性的Meta分析[J]. 中国全科医学, 2021, 24(20): 2594-2600. DOI: 10.12114/j.issn.1007-9572.2021.00.548.
19 李旭芳, 赵明奇, 叶家卫, 等. 新型冠状病毒2型感染儿童后外周血淋巴细胞亚群和血清细胞因子水平变化分析[J]. 免疫学杂志, 2021, 37(9): 796-802. DOI: 10.13431/j.cnki.immunol.j.20210112.
20 赵磊, 秦浩, 戴二黑, 等. 河北省新型冠状病毒肺炎境外输入性病例与本地病例临床特征分析研究[J]. 中国全科医学, 2020, 23(35): 4425-4429. DOI: 10.12114/j.issn.1007-9572.2020.00.596.
基金
国家中医药管理局新型冠状病毒感染肺炎中医药应急专项（2022ZYLCYJ01-2）；河南省中医药科学研究专项课题（2022ZYZD03）。
PDF(553 KB)
